Krystal Biotech (KRYS) Other Gross PP&E Adjustments (2021 - 2025)
Krystal Biotech (KRYS) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with $163.4 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 1.03% to $163.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $163.4 million through Dec 2025, up 1.03% year-over-year, with the annual reading at $163.4 million for FY2025, 1.03% up from the prior year.
- Other Gross PP&E Adjustments hit $163.4 million in Q4 2025 for Krystal Biotech, down from $164.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $167.7 million in Q3 2024 to a low of $32.4 million in Q1 2021.
- Historically, Other Gross PP&E Adjustments has averaged $139.6 million across 5 years, with a median of $160.6 million in 2023.
- Biggest five-year swings in Other Gross PP&E Adjustments: surged 298.23% in 2022 and later fell 2.07% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $105.4 million in 2021, then skyrocketed by 45.1% to $153.0 million in 2022, then increased by 4.31% to $159.6 million in 2023, then rose by 1.34% to $161.7 million in 2024, then grew by 1.03% to $163.4 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for KRYS at $163.4 million in Q4 2025, $164.2 million in Q3 2025, and $164.1 million in Q2 2025.